Final - October 17, 2012

page 1 of 2

PURPOSE PRESIDER/PRESENTER(s)

8:00 Dr. Jonathan Temte (ACIP Chair)

Dr. Larry Pickering (ACIP Executive Secretary; 

CDC)

8:30

Dr. Mark Sawyer (ACIP, WG Chair)

Dr. Sarah Meyer (CDC/NCIRD)

Dr. Jennifer Liang (CDC/NCIRD)

Vote, VFC vote Dr. Jennifer Liang (CDC/NCIRD)

10:30

10:45

Dr. Lorry Rubin (ACIP, WG Chair)

Dr. Jackie Miller (GSK Vaccines)

Dr. Elizabeth Briere (CDC/NCIRD)

Vote Dr. Amanda Cohn (CDC/NCIRD)

VFC Vote Dr. Jeanne Santoli (CDC/NCIRD)

1:00

2:15

Dr. Jonathan Temte (ACIP, WG Chair)

Vote

3:55

4:10

Dr. Renée Jenkins (ACIP, WG Chair)

Dr. Iyabode Beysolow (CDC/NCIRD)

Vote Dr. Iyabode Beysolow (CDC/NCIRD)

5:20

Dr. Tamera Coyne-Beasley (ACIP, WG Chair)

Dr. Carolyn Bridges (CDC/NCIRD)

Vote Dr. Carolyn Bridges (CDC/NCIRD)

5:50 Public Comment

6:00 Adjourn

Information & 

Discussion

Updates to the MMR Statement Information & 

Discussion 

Information & 

Discussion

· Vaccination of HIV-infected persons

· Introduction

· Measles post-exposure prophylaxis with IG

· Immunogenicity and safety of HibMenCY

Break

Adult Immunization Schedule, 2013

· Review statement

Dr. Huong McLean (CDC/NCIRD)

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30333

October 24-25, 2012

AGENDA ITEM

Wednesday, October 24, 2012

· Considerations for use of HibMenCY in infants

· Introduction

· Rationale for vaccinating pregnant women with Tdap

· Considerations for updated recommendation on use of Tdap 

in pregnant women

Meningococcal Vaccines

· GRADE evidence for HibMenCY

Break

· Introduction

· Update on the epidemiology of pertussis in the US and 

Washington state epidemic, 2012

Welcome & Introductions

Pertussis Vaccines

Information & 

Discussion

· Child/adolescent schedule - review of changes, presentation 

of field study results

· Vaccines for Children

Lunch

Measles, Mumps, and Rubella Vaccines

· Introduction

Information & 

Discussion

Child/Adolescent Immunization Schedule, 2013

· Discussion and vote on 2013 schedule

· Introduction

· Adult immunization schedule - review of changes

· Discussion and vote on 2013 schedule
Final -October 17, 2012 

 

 

Thursday, October 25, 2012 

8:00 Unfinished Business 

8:15 Agency Updates 

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH 

8:30 Japanese Encephalitis Work Group Update 

8:35 Hepatitis B Vaccine and Health-Care Personnel (HCP) 

· Current practices; proposed approach

· Introduction 

· Risk of hepatitis B virus infection among HCP 

· Long-term vaccine-induced protection; updates to costeffectiveness analysis

10:00 Break

10:30 Human Papillomavirus (HPV) Vaccines 

· Introduction 

· Progress in vaccine uptake and reasons for non-vaccination: 

NIS-Teen 2007-2011 

· Evaluation of efficacy of HPV in prevention of oral HPV 

infection 

· Progress in monitoring HPV vaccine and future WG plans 

11:15 Rotavirus 

· Detection of vaccine-derived rotavirus strains 

· Update on rotavirus vaccine impact in the U.S. 

12:00 Lunch

11:45 Vaccine Supply 

1:00 Influenza 

· Introduction 

· Influenza activity 

· GSK Quadrivalent Inactivated Vaccine 

· Quadrivalent Influenza Vaccines 

· Cell culture vaccine 

· Influenza vaccines for children 

3:00 Public Comment 

3:15 Adjourn 

Information 

Information 

Information & 

Discussion 

Information 

Information & 

Discussion 

Information 

Information 

& 

Discussion 

VFC vote 

Information 

Dr. Jonathan Temte (Chair, ACIP) 

CDC and Ex Officio members 

Dr. Joseph Bocchini (ACIP, WG Chair) 

Dr. Mark Sawyer (ACIP, WG Chair) 

Dr. Sarah Schillie (CDC/NCHHSTP)

 Dr. Trudy Murphy (CDC/NCHHSTP)

Dr. Sarah Schillie (CDC/NCHHSTP)

Dr. Joseph Bocchini (ACIP, WG Chair) 

Dr. Aimee Kreimer, (NIH/NCI)

Dr. Christine Dorell (CDC/NCIRD) 

Dr. Lauri Markowitz (CDC/NCHHSTP) 

Dr. Daniel Payne, NCIRD/DVD

Dr. Daniel Payne, NCIRD/DVD

Dr. Jeanne Santoli (CDC/NCIRD) 

Dr.Wendy Keitel (ACIP, WG Chair) 

Dr. Lyn Finelli (CDC/NCIRD) 

Dr. Varsha Jain (GlaxoSmithKline)
	

Dr. Jeanne Santoli (CDC/NCIRD)
	

Dr. David Pratt (Novartis)
	

page 2 of 2 

· Influenza vaccine coverage Dr. James Singleton (CDC/NCIRD)
	
	

· Quadrivalent Live Attenuated Influenza Vaccine (Q/LAIV) Dr. Raburn Mallory (MedImmune)
	

Dr. Lisa Grohskopf (CDC/NCIRD)

· Fluzone Quadrivalent Influenza Vaccine for individuals 6 

months of age and older 

Dr. David Greenberg (sanofi pasteur)
	

· Potential public health impact of quadrivalent influenza

vaccines

Dr. Carrie Reed (CDC/NCIRD)